First Trust Direct Indexing’s NeoGenomics NEO Stock Holding History

First Trust Direct Indexing’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,174	Closed	-$136K	–	678
2022 Q1	$136K	Buy	11,174 +3,881	+53%	+$81.7K	0.02%	644
2021 Q4	$249K	Buy	7,293 +52	+0.7%	+$2.04K	0.03%	542
2021 Q3	$349K	Buy	7,241 +90	+1%	+$4.17K	0.05%	437
2021 Q2	$323K	Buy	7,151 +477	+7%	+$21.1K	0.05%	443
2021 Q1	$322K	Buy	6,674 +141	+2%	+$7.34K	0.09%	297
2020 Q4	$352K	Buy	+6,533	New	+$295K	0.09%	262

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

First Trust Direct Indexing's NEO Position: Q2 2022 in Review

First Trust Direct Indexing sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 11,174 shares — an estimated $136K sold.

First Trust Direct Indexing first reported a position in NEO in Q4 2020 and held it in 6 quarters. The position peaked at $352K in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

First Trust Direct Indexing reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
First Trust Direct Indexing sold 11,174 NeoGenomics shares in Q2 2022, an estimated $136K.
First Trust Direct Indexing first reported a position in NeoGenomics in Q4 2020 and held it in 6 quarters.
First Trust Direct Indexing's NeoGenomics position peaked at $352K in Q4 2020.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on First Trust Direct Indexing's 13F filing for Q2 2022, filed 18 Jul 2022.